A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ponatinib Impurity 14 - Request Quote

Picture of Ponatinib Impurity 14

Ponatinib Impurity 14

SZ CAT No:SZ-P133023
CAS No
NA
Mol.F.
C29H27F3N6O3
Mol.Wt.
564.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ponatinib Impurity 14 is chemically 1-(4-(3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylbenzamido)-2-(trifluoromethyl)benzyl)-4-methylpiperazine 1,4-dioxide. Ponatinib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Ponatinib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ponatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ponatinib Impurity 14

Purchase Ponatinib Impurity 14

Ponatinib Impurity 14 suppliers

Ponatinib Impurity 14 manufacturers

Ponatinib Impurity 14 price

Order Ponatinib Impurity 14

Enquire Ponatinib Impurity 14

Ponatinib Impurity 14 cost

Ponatinib Impurity 14 Supplier

Ponatinib Impurity 14 Distributor

Ponatinib Impurity 14 for Method Validation

Ponatinib Reference Standard

Ponatinib Impurity 14 for ANDA Filing

Ponatinib Impurity 14 for Forced Degradation Studies

Ponatinib Impurity 14 Identification Standards

Ponatinib Impurity 14 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,